Rights and permissions
About this article
Cite this article
Scheduled infliximab maintenance worthy for Crohn's disease in UK. Inpharma Wkly. 1650, 5 (2008). https://doi.org/10.2165/00128413-200816500-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816500-00006